Covered recipient · General Payments record
EMILY H HEALY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2024
$549.41
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $549.41 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | $259.09 | 2 |
| ABBVIE INC. | $213.20 | 10 |
| Otsuka America Pharmaceutical, Inc. | $36.73 | 2 |
| Braeburn Inc. | $23.43 | 1 |
| Lundbeck LLC | $16.96 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $549.41 | 16 |
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $109.91 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310935 | CMS |
| ABBVIE INC. | $12.43 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310937 | CMS |
| ABBVIE INC. | $6.56 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310939 | CMS |
| ABBVIE INC. | $12.70 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310941 | CMS |
| ABBVIE INC. | $9.63 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310943 | CMS |
| ABBVIE INC. | $18.10 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310945 | CMS |
| ABBVIE INC. | $12.19 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310947 | CMS |
| ABBVIE INC. | $11.13 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310949 | CMS |
| ABBVIE INC. | $15.37 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310951 | CMS |
| ABBVIE INC. | $5.18 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107310953 | CMS |
| Braeburn Inc. | $23.43 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125613183 | CMS |
| Lundbeck LLC | $16.96 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146033350 | CMS |
| Otsuka America Pharmaceutical, Inc. | $14.03 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119091400 | CMS |
| Otsuka America Pharmaceutical, Inc. | $22.70 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119091402 | CMS |
| Supernus Pharmaceuticals, Inc. | $125.00 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147896797 | CMS |
| Supernus Pharmaceuticals, Inc. | $134.09 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147896799 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.